Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the α-thalassemia myelodysplasia syndrome (ATMDS)

Nature Genetics

Volumn 34, Issue 4, 2003, Pages 446-449

  Gibbons, Richard J ^a   Pellagatti, Andrea ^a   Garrick, David ^a   Wood, William G ^a   Malik, Nicola ^a   Ayyub, Helena ^a   Langford, Cordelia ^b   Boultwood, Jacqueline ^a   Wainscoat, James S ^a   Higgs, Douglas R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRX PROTEIN; CHROMATIN REMODELING FACTOR; GENE PRODUCT; UNCLASSIFIED DRUG;

ALPHA THALASSEMIA; ALPHA THALASSEMIA MYELODYSPLASIA SYNDROME; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; GLOBIN GENE; HUMAN; HUMAN CELL; MYELODYSPLASIA; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION; SYNDROME;

ALPHA-THALASSEMIA; BASE SEQUENCE; BONE MARROW CELLS; CASE-CONTROL STUDIES; DNA; DNA HELICASES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLOBINS; HUMANS; MALE; MUTATION; MYELODYSPLASTIC SYNDROMES; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE;

EID: 20244389965     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng1213     Document Type: Article

References (16)

1. Higgs, D.R. et al. A review of the molecular genetics of the human α-globin gene cluster. Blood 73, 1081-1104 (1989).
2. Gibbons, R.J. & Higgs, D.R. The molecular-clinical spectrum of the ATR-X syndrome. Am. J. Med. Genet. 97, 204-212 (2000).
3. Gibbons, R.J., Picketts, D.J., Villard, L. & Higgs, D.R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATRX syndrome). Cell 80, 837-845 (1995).
4. McDowell, T.L. et al. Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc. Natl. Acad. Sci. USA 96, 13983-13988 (1999).
5. Berube, N.G., Smeenk, C.A. & Picketts, D.J. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum. Mol. Genet. 9, 539-547 (2000).
6. Weatherall, D.J. et al. Acquired haemoglobin H disease in leukaemia: pathophysiology and molecular basis. Br. J. Haematol. 38, 305-322 (1978).
7. Higgs, D.R., Wood, W.G., Barton, C. & Weatherall, D.J. Clinical features and molecular analysis of acquired HbH disease. Am. J. Med. 75, 181-191 (1983).
8. Higgs, D.R. & Bowden, D.K. Clinical and laboratory features of α-thalassemia syndromes. in Disorders of Hemoglobin (ed. Nagel, R.L.) 431-469 (Cambridge University Press, Cambridge, 2001).
9. Craddock, C.F. et al. Contrasting effects of α and β globin regulatory elements on chromatin structure may be related to their different chromosomal environments. EMBO J. 14, 1718-1726 (1995).
10. Higgs, D.R., Sharpe, J.A. & Wood, W.G. Understanding α-globin gene expression: a step towards effective gene therapy. Semin. Hematol. 35, 93-104 (1998).
11. Wilkie, A.O.M. et al. Clinical features and molecular analysis of the α-thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the α-globin complex. Am. J. Hum. Genet. 46, 1127-1140 (1990).
12. Wada, T. & Gibbons, R.J. ATR-X syndrome. in Genetics and Genomics of Neurobehavioural Disorders (ed. Fisch, G.S.) 309-334 (Humana, Totowa, New Jersey, 2003).
13. Krebs, J.E., Fry, C.J., Samuels, M.L. & Peterson, C.L. Global role for chromatin remodeling enzymes in mitotic gene expression. Cell 102, 587-598 (2000).
14. Takeda, J. et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73, 703-711 (1993).
15. Nafa, K., Bessler, M., Castro-Malaspina, H., Jhanwar, S. & Luzzatto, L. The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol. Dis. 24, 370-384 (1998).
16. Happle, R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin. Genet. 29, 321-324 (1986).